Use of Gastrografin in the Management of Fecal Impaction in Patients With Severe Chronic Constipation
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Fecal impaction (FI) is a common cause of lower gastrointestinal tract obstruction, and it is
the result of chronic or severe constipation and most commonly found in the elderly
population. Gastrografin is a water soluble contrast mediate that could act as an osmotic
laxative. It has been shown to confer a therapeutic beneļ¬t in adhesive small bowel
obstruction (SBO). The investigators speculate that gastrografin administrated orally may be
more effective than enema in the treatment of fecal impaction induced intestinal obstruction.